AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
87. The Label (Johnson & Johnson)
Swindled
Johnson & Johnson Pharmaceuticals - A New Drug That Works for Children With Autism
Johnson & Johnson lobbied a dozen states to adopt Rispertol as its preferred first-line medication for schizophrenia. The drug was originally approved only for skits of finny adults, but by the late 90s it had become popular with children and adolescents. In 2004, there was mounting evidence that RispertOL had potentially serious side effects that Johnson & Johnson had failed to clarify.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode